| 臺大學術典藏 |
2020-12-02T11:04:27Z |
2019 focused update of the guidelines of the Taiwan society of cardiology for the diagnosis and treatment of heart failure
|
Tsai C.-T.; Wu Y.-W.; Lin J.-L.; Yin W.-H.; Cherng W.-J.; Su C.-H.; Tsai J.-P.; Lu Y.-Y.; Wang C.-H.; Chang H.-Y.; Chang W.-T.; Tzeng B.-H.; Yen H.-W.; Chi N.-H.; Huang J.-L.; Chou H.-H.; Huang W.-C.; Lee C.-M.; Tsai M.-L.; Wang C.-C.; CHO-KAI WU; Hwang J.-J. |
| 臺大學術典藏 |
2020-12-01T08:29:10Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Lin S.-Y.; Lin T.-H.; TZUNG-DAU WANG; Yeh H.-I.; Chen J.-F.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; Wu Y.-W.; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L. |
| 臺大學術典藏 |
2020-11-12T03:02:45Z |
Primary study of L-arginine on the concentrations of serum lipids in human
|
PEY-RONG CHEN; Tsai C.;Yin W.-H.;Cheng H.-C.;Pey-Rong Chen;Lin Y.-L.; Tsai C.; Yin W.-H.; Cheng H.-C.; Lin Y.-L. |
| 臺大學術典藏 |
2020-11-12T03:02:43Z |
2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the diagnosis and treatment of heart failure
|
Cherng W.-J.; Pai H.-Y.; PEY-RONG CHEN; Liu M.-H.; Fu T.-C.; Wang C.-H.; Tsai F.-C.; Huang J.-L.; Ueng K.-C.; Chen P.-S.; Lin W.-S.; Wu C.-C.; Li A.-H.; Yin W.-H.; Cheng J.-J.; Yu W.-C.; Chen J.-H.; Wang C.-C.; Wang C.-C.;Chen J.-H.;Yu W.-C.;Cheng J.-J.;Yin W.-H.;Wu C.-C.;Li A.-H.;Lin W.-S.;Chen P.-S.;Ueng K.-C.;Huang J.-L.;Tsai F.-C.;Wang C.-H.;Fu T.-C.;Liu M.-H.;Pey-Rong Chen;Pai H.-Y.;Cherng W.-J. |
| 臺大學術典藏 |
2020-09-30T08:49:31Z |
TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management
|
YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Wang C.-C.; Chang H.-Y.; Yin W.-H. |
| 臺大學術典藏 |
2020-09-30T08:49:30Z |
The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients
|
Lin G.-M.; Li Y.-H.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I. |
| 臺大學術典藏 |
2020-09-30T08:49:28Z |
One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry
|
Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Yin W.-H.; Huang J.-L.; Lin W.-S.; Voon W.-C.; Hsu C.-H.; Wen M.-S.; Wu C.-C.; Chu P.-H.; YEN-WEN WU; Wang C.-C.; Chang H.-Y. |
| 臺大學術典藏 |
2020-09-30T08:49:28Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:27Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-09-30T08:49:25Z |
In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry
|
Chen K.-C.; Yin W.-H.; Wu C.-C.; Chan S.-H.; YEN-WEN WU; Wang K.Y.; Chang K.-C.; Hwang J.-J.; Voon W.-C.; Hsieh I.-C.; Chong J.-T.; Lin W.-S.; Hsu C.-N.; Ueng K.-C.; Hsia C.-P.; Liu J.-C.; Yeh J.-S.; Mar G.-Y.; Shih J.-Y.; Kuo J.-Y.; Tsao H.-M.; Tseng W.-K.; Yang C.-H.; Chang C.-C.; Chiang C.-E.; Lei M.-H.; Lin J.-F.; Shyu K.-G. |
| 臺大學術典藏 |
2020-09-30T08:49:25Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L.; Shyu K.-G.; Chao T.-H.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chen J.-F.; Yeh H.-I.; Wang T.-D.; Lin T.-H.; Lin S.-Y.; Chiang C.-E. |
| 臺大學術典藏 |
2020-09-30T08:49:23Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Tseng W.-K.; YEN-WEN WU; Ho S.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:23Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators; Ho L.-T.; Lin F.-J. |
| 臺大學術典藏 |
2020-09-30T08:49:22Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Wu C.-C.; Hwang J.-J.; Chang K.-C.; Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; YEN-WEN WU; Wang K.-Y.; Hsieh M.-Y.; Pan S.-L.; Li H.-Y.; Jong C.-B. |
| 臺大學術典藏 |
2020-09-30T08:49:20Z |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:19Z |
2019 focused update of the guidelines of the Taiwan society of cardiology for the diagnosis and treatment of heart failure
|
Wang C.-C.; Wu C.-K.; Tsai M.-L.; Lee C.-M.; Huang W.-C.; Chou H.-H.; Huang J.-L.; Chi N.-H.; Yen H.-W.; Tzeng B.-H.; Chang W.-T.; Chang H.-Y.; Wang C.-H.; Lu Y.-Y.; Tsai J.-P.; Su C.-H.; Cherng W.-J.; Yin W.-H.; Tsai C.-T.; YEN-WEN WU; Lin J.-L.; Hwang J.-J. |
| 臺大學術典藏 |
2020-09-30T08:49:18Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions
|
Chen J.-W.; Yeh H.-I.; National Taiwan Biosignature Research Investigators; Tsai H.-Y.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Wang J.-H.; Chang K.-C.; Lin T.-H.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Ho S.-K.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J.; Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I. |
